# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Extrahepatic bile duct cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 46 results.
RFA RCT for Pancreatic or Bile Duct Cancer
Status: Recruiting
Last Changed: Mar 30, 2018
First Received: Jun 18, 2014
Disease(s): Unresectable Pancreatic Cancer, Cholangiocarcinoma Non-resectable
Intervention(s): Radiofrequency Ablation using EndoHPB Probe, Stenting only
Locations: Weill Cornell Medical College, New York, New York, United States
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Status: Recruiting
Last Changed: May 20, 2019
First Received: Jul 09, 2018
Disease(s): Resectable Cholangiocarcinoma, Stage IB Intrahepatic Cholangiocarcinoma AJCC v8, Stage II Intrahepatic Cholangiocarcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8
Intervention(s): Cisplatin, Gemcitabine, Nab-paclitaxel
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
Emory University Hospital Midtown, Atlanta, Georgia, United States
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
... and 4 other locations.
A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
Status: Not yet recruiting
Last Changed: Jul 10, 2019
First Received: Jul 10, 2019
Disease(s): Liver Cancer, Pancreas Cancer, Stomach Cancer, Bile Duct Cancer
Intervention(s): Endovascular Denervation
Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Status: Recruiting
Last Changed: Dec 11, 2018
First Received: Dec 11, 2018
Disease(s): Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer
Intervention(s): mutation and signal pathway activation status analysis Drug: FORFIRINOX
Locations: Xinhua Hospital, Shanghai, Shanghai, China
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Status: Recruiting
Last Changed: Dec 07, 2018
First Received: Dec 07, 2018
Disease(s): Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer
Intervention(s): conventional chemotherapy(FORFIRINOX) combined with target agents, conventional chemotherapy(FORFIRINOX)
Locations: Xinhua Hospital, Shanghai, Shanghai, China
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Status: Recruiting
Last Changed: May 07, 2018
First Received: Jul 19, 2016
Disease(s): Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer
Intervention(s): biological test, GEMOX, Cetuximab, Trastuzumab, Gefitinib, Lapatinib, Everolimus, Sorafenib, Crizotinib
Locations: Xinhua Hospital, Shanghai, Shanghai, China
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
Status: Recruiting
Last Changed: Sep 09, 2019
First Received: Dec 07, 2018
Disease(s): Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Distal Bile Duct Cancer AJCC v8, Stage IIIA Gallbladder Cancer AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Distal Bile Duct Cancer AJCC v8, Stage IIIB Gallbladder Cancer AJCC v8, Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Distal Bile Duct Cancer AJCC v8, Stage IV Gallbladder Cancer AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8, Stage IVA Gallbladder Cancer AJCC v8, Stage IVB Gallbladder Cancer AJCC v8, Unresectable Extrahepatic Bile Duct Carcinoma, Unresectable Gallbladder Carcinoma, Unresectable Intrahepatic Cholangiocarcinoma
Intervention(s): Cisplatin, Gemcitabine Hydrochloride, Nab-paclitaxel
Locations: Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
Alaska Women's Cancer Care, Anchorage, Alaska, United States
... and 578 other locations.
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program
Status: Recruiting
Last Changed: May 23, 2019
First Received: Mar 23, 2018
Disease(s): Pancreatic Cancer, Liver Cancer, Bile Duct Cancer, Hepatobiliary Cancer, Surgery
Intervention(s): Exercise, Nutrition, Relaxation techniques
Locations: McGill University Health Centre, Montreal, Quebec, Canada
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)
Status: Recruiting
Last Changed: Sep 18, 2019
First Received: Apr 13, 2017
Disease(s): Biliary Tract Neoplasms, Cholangiocarcinoma, Bile Duct Cancer, Liver Cancer, Gallbladder Cancer
Intervention(s): Pembrolizumab (MK-3475), Oxaliplatin, Capecitabine
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy
Status: Recruiting
Last Changed: Jul 03, 2019
First Received: Aug 03, 2016
Disease(s): Gastric Cancer, Pancreas Cancer, Bile Duct Cancer, Gastroesophageal Cancer, Esophageal Cancer
Intervention(s): Early Palliative Care visit, EORTC-QLQ-C30 questionnaire, HADS score
Locations: Institut de cancérologie de l'Ouest-site PAUL, Angers, France
CH de Béthune, Beuvry, France
Centre Hospitalier Boulogne sur Mer, Boulogne sur Mer, France
Centre François Baclesse, Caen, Caen, France
Centre Georges Francois Leclerc de DIJON, Dijon, France
... and 16 other locations.